Gérard Zalcman - Dissemin

All papers authored by Gérard Zalcman

This paper was not found in any repository, but could be made available legally by the author.

2023 Guénaëlle Levallet

, Fatéméh Dubois, Nicolas Elie, Christian Creveuil, Solenn Brosseau, Claire Danel, Arnaud Scherpereel, Sylvie Lantuejoul, Julien Mazières, Laurent Greillier, Clarisse Audigier-Valette, Emmanuel Bergot, Denis Moro-Sibilot, Olivier Molinier, Hervé Léna and 4 other authors

VEGFR2 and CD34 expression associated with longer survival in patients with pleural mesothelioma in the IFCT-GFPC-0701 MAPS phase 3 trial

Upload

V. Gounant, S. Brosseau, C. Lorut, N. Guezour, C. Vauchier, W. Mohammad, A. Khalil, G. Zalcman

Urgences respiratoires (non infectieuses) du patient d’onco-hématologie

Upload

This paper is made freely available by the publisher.

Athéna Crespin, Clément Le Bescop, Jean de Gunzburg, Fabien Vitry, Gérard Zalcman

, Julie Cervesi, Pierre-Alain Bandinelli

A systematic review and meta-analysis evaluating the impact of antibiotic use on the clinical outcomes of cancer patients treated with immune checkpoint inhibitors

Download from doi.org

François-Xavier Danlos, Matthieu Texier

, Bastien Job

, Severine Mouraud

, Lydie Cassard

, Capucine Baldini

, Andrea Varga

, Andrey A. Yurchenko

, Audrey Rabeau

, Stéphane Champiat

, Diane Letourneur

, Delphine Bredel

, Sandrine Susini

, Yuna Blum

, Aurelien Parpaleix

and 28 other authors

Genomic Instability and Protumoral Inflammation Are Associated with Primary Resistance to Anti–PD-1 + Antiangiogenesis in Malignant Pleural Mesothelioma

Upload

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Lisa Derosa, Carolina Alves Costa Silva, Valerio Iebba, Bertrand Routy, Anna Reni, Clarisse Audigier-Valette, Gerard Zalcman

, Julien Mazieres, Sylvie Friard, Francois Goldwasser, Denis Lucien Moro Sibilot, Arnaud Scherpereel, Herve Pegliasco, Stephanie Martinez, Bernard Escudier and 5 other authors

Friendly-user score assessing gut dysbiosis and resistance to immune checkpoint inhibitors (ICI)

Upload

Anne-Marie C. Dingemans, Konstantinos Syrigos, Lorenzo Livi, Astrid Paulus, Sang-We Kim, Yuanbin Chen, Enriqueta Felip, Frank Griesinger, Kadoaki Ohashi, Gerard Zalcman

, Brett Gordon Maxwell Hughes, Jens Benn Sorensen, Normand Blais, Carlos G. M. Ferreira, Colin R. Lindsay and 5 other authors

Intracranial efficacy of sotorasib versus docetaxel in pretreated KRAS G12C-mutated advanced non-small cell lung cancer (NSCLC): Practice-informing data from a global, phase 3, randomized, controlled trial (RCT)

Upload

Quincy S. Chu, Maria Carmela Piccirillo, Laurent Greillier, Federica Grosso, Giuseppe Lo Russo, Marie Florescu, Manlio Mencoboni, Penelope Ann Bradbury, Alessandro Morabito, Fabiana Letizia Cecere, Sara Delfanti, Arnaud Scherpereel, Myriam Locatelli-Sanchez, Gerard Zalcman

, David E. Dawe and 5 other authors

IND227 phase III (P3) study of cisplatin/pemetrexed (CP) with or without pembrolizumab (pembro) in patients (pts) with malignant pleural mesothelioma (PM): A CCTG, NCIN, and IFCT trial

Upload

Gerard Zalcman

, Anne Madroszyk, Charles Dayen, Olivier Molinier, Thomas Egenod, Didier Debieuvre, Sophie Beaucaire-Danel, Adrien Dixmier, Eric Pichon, Sigole Ne Galland-Girodet, Etienne Giroux Leprieur, Nicolas Cloarec, Jacques Cadranel, Josiane Otto, Nicolas Pote and 5 other authors

Nivolumab (Nivo) plus ipilimumab (Ipi) 6-month treatment versus continuation in patients with advanced non-small-cell-lung cancer (aNSCLC): 3-year results of the IFCT-1701 DICIPLE phase 3 trial

Upload

2022 L. Derosa, C. Alves Costa Silva, V. Iebba, B. Routy, A. Reni, C. Audigier-Valette, G. Zalcman

, J. Mazieres, S. Friard, F. Goldwasser, D. Moro-Sibilot, A. Scherpereel, H. Pegliasco, S. Martinez, B. Escudier and 5 other authors

259MO A predictive score of cancer immunotherapy responses based on ecological analysis of gut microbiota

Upload

Arianna Mencattini, Christine Lansche, Irina Veith, Philippe Erbs, Jean-Marc Balloul, Eric Quemeneur, Stéphanie Descroix, Fatima Mechta-Grigoriou, Gérard Zalcman

, Cécile Zaupa, Maria Carla Parrini, Eugenio Martinelli

Direct imaging and automatic analysis in tumor-on-chip reveal cooperative antitumoral activity of immune cells and oncolytic vaccinia virus

Upload

Marie Wislez

, Julien Mazieres

, Armelle Lavole, Gérard Zalcman

, Olivier Carre, Thomas Egenod, Raffaele Caliandro, Catherine Dubos-Arvis, Gaelle Jeannin, Olivier Molinier, Marie-Ange Massiani, Alexandra Langlais, Franck Morin

, Francoise Le Pimpec Barthes, Laurent Brouchet and 5 other authors

Neoadjuvant durvalumab for resectable non-small-cell lung cancer (NSCLC): results from a multicenter study (IFCT-1601 IONESCO)

Download from doi.org

E. Guenzi, K. El Husseini, A. Guyard, A. Mailleux, P. Mordant, A. Couvelard, B. Crestani, A. Cazes, G. Zalcman

, N. Poté

Cancer associated fibroblasts subtypes are associated with histological features, immune environment and prognosis in resected non small cell lung cancer

Upload

A. Brudon, N. Nathan, M. Legendre, S. Amselem, J. Bermudez, D. Bouvry, J. Cadranel, A. Cazes, T. Degot, C. Delestrain, R. Diesler, R. Epaud, P. Fanen, A. Gondouin, A. Guillaumot and 13 other authors

High Prevalence and impact of lung cancer in Surfactant related gene mutation carriers

Upload

G. Zalcman

, A.-C. Madroszyk Flandin, O. Molinier, C. Dayen, T. Egenod, D. Debieuvre, S. Beaucaire-Danel, A. Dixmier, E. Pichon, S. Galland Girodet, E. Giroux-Leprieur, N. Cloarec, J. Cadranel, J. Otto, P. Romand and 5 other authors

972O Nivolumab (Nivo) plus ipilimumab (Ipi) 6-months treatment versus continuation in patients with advanced non-small cell lung cancer (aNSCLC): Results of the randomized IFCT-1701 phase III trial

Upload

G. Zalcman

, Y. Oulkhouir, R. Cornelissen, L. Greillier, J. R. Rodriguez Cid, J. Mazieres, P. Briggs, A. K. Nowak, A. Tsao, N. Fujimoto, S. Peters, A. S. Mansfield, S. Popat, A. Nassar, J. Bushong and 5 other authors

LBA71 First-line nivolumab (NIVO) plus ipilimumab (IPI) vs chemotherapy (chemo) in patients (pts) with unresectable malignant pleural mesothelioma (uMPM): 4-year update from CheckMate 743

Upload

F.-X. Danlos, C. Baldini, M. Texier, A. Varga, S. Mouraud, B. Job, D. Letourneur, L. Cassard, D. Bredel, S. Laghouati, J. Adam, N. Droin, A. Parpaleix, N. Chaput-Gras, A. Rabeau and 5 other authors

1661MO Genomic somatic copy number alterations drive adaptive tumor immune suppression and primary resistance to anti-PD1 + anti-angiogenics in pleural mesothelioma

Upload

Virginie Westeel, Pascal Foucher, Arnaud Scherpereel, Jean Domas, Philippe Girard, Jean Trédaniel, Marie Wislez, Patrick Dumont, Elisabeth Quoix, Olivier Raffy, Denis Braun, Marc Derollez, François Goupil, Jacques Hermann, Etienne Devin and 21 other authors

Chest CT scan plus x-ray versus chest x-ray for the follow-up of completely resected non-small-cell lung cancer (IFCT-0302): a multicentre, open-label, randomised, phase 3 trial

Upload

J. Trédaniel, F. Barlési, C. Le Péchoux, D. Lerouge, É. Pichon, S. Le Moulec, L. Moreau, S. Friard, V. Westeel, L. Petit, O. Carré, F. Guichard, O. Raffy, J. Villa, A. Prévost and 6 other authors

Final results of the IFCT-0803 study, a phase II study of cetuximab, pemetrexed, cisplatin, and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non-squamous, non-small-cell lung cancer

Upload

Mateo Sanchis-Borja, Vincent Fallet, Elisabeth Fabre, Marie Wislez, Stéphane Culine, Gérard Zalcman

, Jean-Philippe Spano, Nathalie Chabbert Buffet, Nathalie Chabbert Buffet, Florence Coulet, Patrick R. Benusiglio, Jacques Cadranel

Characterization of lung cancers in patients with BRCA germline variants: a multicenter series

Upload

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

All papers authored by Gérard Zalcman